Asenapine

Sycrest 5 MG Comprimidos Sublinguales

5 mg comprimido sublingualSpainMarketedAuthorised 22 Feb 2023

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Asenapine

Sycrest 5 MG Comprimidos Sublinguales

5 mg comprimido sublingualSpainMarketedAuthorised 22 Feb 2023

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Asenapine MaleateUnited States · 10MG BASE, 2.5MG BASE, 5MG BASE · tablet · Sigmapharm Labs LLC

SaphrisUnited States · 10MG BASE, 2.5MG BASE, 5MG BASE · tablet · Abbvie

SaphrisBrazil · Merck Sharp & Dohme Farmaceutica Ltda.

SecuadoUnited States · 3.8MG/24HR, 5.7MG/24HR, 7.6MG/24HR · system · Hisamitsu

Packs

Pack	Code	Status
SYCREST 5 MG COMPRIMIDOS SUBLINGUALES, 60 comprimidos	762293

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Asenapine
Strength: 5 mg
Dosage form: comprimido sublingual
Route: vía sublingual
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 22 Feb 2023
Registration: 10640002IP2
Marketing authorisation holder: Organon N.V.
Procedure: EU centralised
Supply: Medicamento Sujeto A Prescripción Médica

Sycrest 10 MG Comprimidos SublingualesAsenapine · 10 mg · comprimido sublingualSpain

Sycrest 5 MG Comprimidos SublingualesAsenapine · 5 mg · comprimido sublingualSpain

Sycrest 10 MG Comprimidos SublingualesAsenapine · 10 mg · comprimido sublingualSpain

Sycrest 5 MG Comprimidos SublingualesAsenapine · 5 mg · comprimido sublingualSpain